Stephen Huhn
Technik-/Wissenschafts-/F&E-Leiter bei CONTINEUM THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Carmine Stengone | M | 48 | 6 Jahre | |
| Lori Lyons-Williams | F | 46 | 4 Jahre | |
| Daniel Lorrain | M | 55 | 7 Jahre | |
| Todd Brady | M | 45 | 5 Jahre | |
| Evert Schimmelpennink | M | 52 | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ian John Massey | M | 73 |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 1 Jahre |
| Ken Stratton | M | 55 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 14 Jahre |
| Rodney Young | M | 61 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 8 Jahre |
| Bradley Mitchell | M | - |
University of Arizona
| 7 Jahre |
| Neal A. Eckel | M | - |
University of Arizona
| 7 Jahre |
| Charles E. Lemieux | M | - |
University of Arizona
| 4 Jahre |
| Stewart Craig | M | 63 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 6 Jahre |
| Gregory Schiffman | M | 67 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 2 Jahre |
| R. Greer | M | 65 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 6 Jahre |
| Alan Osborne Trounson | M | 78 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 2 Jahre |
| Roger Perlmutter | M | 71 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 13 Jahre |
| Dana Wells | M | - |
University of Arizona
| 4 Jahre |
| Yong-Hee Lee | M | 69 |
University of Arizona
| 3 Jahre |
| James Gregory Garrett | M | - |
University of Arizona
| 4 Jahre |
| Teryn Grater | F | - |
University of Arizona
| 4 Jahre |
| Jim Tofel | M | - |
University of Arizona
| 4 Jahre |
| Tom Casey | M | 55 |
University of Arizona
| 4 Jahre |
| Jay C. Voorhees | M | - |
University of Arizona
| 4 Jahre |
| Lawrence C. Schaffer | M | 55 |
University of Arizona
| 4 Jahre |
| Khalid Al-Majid | M | - |
University of Arizona
| 4 Jahre |
| Guo Cheng Pan | M | 67 |
University of Arizona
| 3 Jahre |
| Jordan S. Simon | M | - |
University of Arizona
| 4 Jahre |
| Mack Dickerson | M | - |
University of Arizona
| 4 Jahre |
| Chrisann Karches | F | - |
University of Arizona
| 4 Jahre |
| Steven Golan | M | - |
University of Arizona
| 4 Jahre |
| Kenneth Ross Hyman | M | - |
University of Arizona
| 4 Jahre |
| Martha Heitzmann-Crawford | M | 56 |
University of Arizona
| 4 Jahre |
| Ali Al-Emadi | M | - |
University of Arizona
| 4 Jahre |
| Steven DenBaars | M | 62 |
University of Arizona
| 4 Jahre |
| David Peter Brady | M | - |
University of Arizona
| 4 Jahre |
| Randy Groth | M | - |
University of Arizona
| 3 Jahre |
| Ben Bucci | M | - |
University of Arizona
| 2 Jahre |
| dan torgerson | M | - |
University of Arizona
| 3 Jahre |
| Valerie Barrett | F | - |
University of Arizona
| 4 Jahre |
| Elliot Begoun | M | - |
University of Arizona
| 4 Jahre |
| Larry Shurtz | M | - |
University of Arizona
| 4 Jahre |
| John F. Chin | M | 58 |
University of Arizona
| 4 Jahre |
| Kaushal Agrawal | M | - |
University of Arizona
| 3 Jahre |
| Robert Lee | M | - |
University of Arizona
| 5 Jahre |
| Peter M. Zymali | M | - |
University of Arizona
| 14 Jahre |
| Scott T. McBride | M | - |
University of Arizona
| 3 Jahre |
| Robin Schlimgen | F | - |
University of Arizona
| 3 Jahre |
| Saeed Mubarak Al-Muharrami | M | - |
University of Arizona
| 4 Jahre |
| Chang-Jo Yoo | M | 65 |
University of Arizona
| 4 Jahre |
| Jeffrey Scott Schwaber | M | - |
University of Arizona
| 4 Jahre |
| David McCauley | M | - |
University of Arizona
| 3 Jahre |
| John E. Rice | M | - |
University of Arizona
| 4 Jahre |
| Naymisha Patel | F | - |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | - |
| Steven Dischler | M | 65 |
University of Arizona
| 1 Jahre |
| Daniel Ratner | M | 61 |
University of Arizona
| 4 Jahre |
| Paul E. Damphousse | M | - |
University of Arizona
| 4 Jahre |
| Glenn Rosenberg | M | - |
University of Arizona
| 3 Jahre |
| Guy W. McElvain | M | - |
University of Arizona
| 4 Jahre |
| Brent D. Mittelstadt | M | - |
University of Arizona
| 4 Jahre |
| Louise Goudy Willmering | F | - |
University of Arizona
| 4 Jahre |
| Peter Megaw | M | 71 |
University of Arizona
| 3 Jahre |
| Don N. Aquilano | M | 57 |
University of Arizona
| 4 Jahre |
| Susan L. Ernsky | F | - |
University of Arizona
| 2 Jahre |
| Dana Bradford | M | 59 |
University of Arizona
| 4 Jahre |
| Stephen Capp | M | 62 |
University of Arizona
| 4 Jahre |
| Theodore Howard Harper | M | - |
University of Arizona
| 4 Jahre |
| Craig A. Norris | M | 56 |
University of Arizona
| 4 Jahre |
| Brendan Thomas Healy | M | - |
University of Arizona
| 4 Jahre |
| Bernie Allen | M | - |
University of Arizona
| 5 Jahre |
| Todd Belfer | M | 56 |
University of Arizona
| 4 Jahre |
| Chris Ackerley | M | - |
University of Arizona
| 4 Jahre |
| Des H. O’Connell | M | 88 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 1 Jahre |
| H. Jay Winship | M | 56 |
University of Arizona
| 4 Jahre |
| Dwight Nixon | M | - |
University of Arizona
| 4 Jahre |
| Marc J. Knez | M | - |
University of Arizona
| 4 Jahre |
| George Jeff Smith | M | 68 |
University of Arizona
| 4 Jahre |
| Philip A. Spencer | M | 54 |
University of Arizona
| 4 Jahre |
| Jeffrey Black | M | 55 |
University of Arizona
| 4 Jahre |
| Doug Moore | M | - |
University of Arizona
| 4 Jahre |
| Eduardo Saavedra | M | - |
University of Arizona
| 4 Jahre |
| Howard R. Elliott | M | - |
University of Arizona
| 4 Jahre |
| John Lai | M | 60 |
University of Arizona
| 4 Jahre |
| Steve Prado | M | - |
University of Arizona
| 4 Jahre |
| Scott Meder | M | - |
University of Arizona
| 4 Jahre |
| Manuel T. Pacheco | M | 82 |
University of Arizona
| 13 Jahre |
| Joel Naor | M | - |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | - |
| Jon Baird | M | - |
University of Arizona
| 14 Jahre |
| Phillip Wickham | M | - |
University of Arizona
| 4 Jahre |
| Jeffrey R. Gerlach | M | - |
University of Arizona
| 4 Jahre |
| John McKinney | M | 63 |
University of Arizona
| 4 Jahre |
| Paul Silber | M | - |
University of Arizona
| 4 Jahre |
| Robert K. Casey | M | - |
University of Arizona
| 4 Jahre |
| Bill R. Metzler | M | - |
University of Arizona
| 4 Jahre |
| John D. Musil | M | - |
University of Arizona
| 4 Jahre |
| David B. Blake | M | 55 |
University of Arizona
| 4 Jahre |
| Christopher J. C. Halligan | M | 57 |
University of Arizona
| 4 Jahre |
| Robert Hinchcliffe | M | 56 |
University of Arizona
| 4 Jahre |
| Liz Merritt | F | - |
University of Arizona
| 4 Jahre |
| Sherman Chu | M | - |
University of Arizona
| 4 Jahre |
| Bill LeBoeuf | M | - |
University of Arizona
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Stephen Huhn
- Persönliches Netzwerk
